Recent study aimed to compare the outcomes of opioid-free anesthesia (OFA) and opioid-based anesthesia (OBA) with ...

Rock out to technical death metal with Malignancy featuring Concrete, or continue your St. Patrick’s Day celebrations with ...

Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces ...

The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

Therapy-related B-cell acute lymphoblastic leukemia (B-ALL), a rare form of acute lymphoblastic leukemia (ALL), may develop in patients receiving cytotoxic treatments for a prior malignancy, according ...

Mortality among persistently aPL-positive patients was associated with arterial thrombosis, concomitant systemic autoimmune diseases, and CVD risk factors.

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

Tredence is shifting towards probabilistic systems, which focus on decision-making based on probability, risk, and contextual ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

The following is a summary of “Improving prostate brachytherapy outcomes through MRI-Assisted dominant lesion dose painting,” published in the March 2025 issue of BMC Urology by Rahmani et al.

Colon cancer is increasingly affecting younger generations, with many cases being aggressive and diagnosed late. A woman's ...